"Normal" liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 4, 2012, Pages 781-788

  Kim, Beom Kyung ^a,b   Kim, Seung Up ^a,b   Choi, Gi Hong ^a,b   Han, Woong Kyu ^a   Park, Mi Sung ^a   Kim, Eun Hye ^a   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Choi, Jin Sub ^a,b   Yang, Seung Choul ^a   Choi, Eun Hee ^a   Song, Kijun ^a   Ahn, Sang Hoon ^a,b   Han, Kwang Hyub ^a,b   Chon, Chae Yoon ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

Author keywords

Healthy individual; Liver stiffness measurement; Sex; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIGESTIVE TRACT PARAMETERS; DONOR SELECTION; FEMALE; HEART DISEASE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER DISEASE; LIVER STIFFNESS; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; THROMBOCYTE COUNT;

EID: 84863342821     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06962.x     Document Type: Article

References (38)

1. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-13.
2. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
3. Corpechot C, El Naggar A, Poujol-Robert A etal. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-24.
4. Kim do Y, Kim SU, Ahn SH etal. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig. Dis. Sci. 2009; 54: 1758-63.
5. de Ledinghen V, Beaugrand M, Kelleher TB. Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): risk factors and diagnostic potential of liver elasticity using Fibroscan. J. Hepatol. 2006; 44: S39.
6. Boursier J, Konate A, Guilluy M etal. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur. J. Gastroenterol. Hepatol. 2008; 20: 693-701.
7. Fraquelli M, Rigamonti C, Casazza G etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
8. Kettaneh A, Marcellin P, Douvin C etal. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 2007; 46: 628-34.
9. Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999; 29: 719-27.
10. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol. 2001; 34: 730-9.
11. Di Martino V, Lebray P, Myers RP etal. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004; 40: 1426-33.
12. Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J. Hepatol. 2008; 48: 606-13.
13. Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J. Gastrointestin. Liver Dis. 2009; 18: 57-60.
14. Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? Hepatology 2006; 44: 513-4.
15. Colombo S, Belloli L, Buonocore M. Liver stiffness values in the normal population: a studying voluntary blood donors. Hepatology 2008; 48 (Suppl.): A995.
16. Kim SU, Choi GH, Han WK etal. What are "true normal" liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 2010; 30: 268-74.
17. Kim SU, Han KH, Ahn SH. Transient elastography in chronic hepatitis B: an Asian perspective. World J. Gastroenterol. 2010; 16: 5173-80.
18. Trotter JF, Wachs M, Trouillot T etal. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl. 2000; 6: 290-5.
19. Marcos A. Right lobe living donor liver transplantation: a review. Liver Transpl. 2000; 6: 3-20.
20. Kasiske BL, Bia MJ. The evaluation and selection of living kidney donors. Am. J. Kidney Dis. 1995; 26: 387-98.
21. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-62.
22. Kim SU, Ahn SH, Park JY etal. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J. Clin. Gastroenterol. 2009; 43: 267-71.
23. Bland M. An Introduction to Medical Statistics, 3rd edn. Oxford: Oxford University Press, 2000.
24. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 1971; 285: 1441-6.
25. Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver Int. 2008; 28: 1408-16.
26. Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol. Res. 2007; 37: 239-47.
27. Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int. 2003; 23: 63-9.
28. Poynard T, Mathurin P, Lai CL etal. A comparison of fibrosis progression in chronic liver diseases. J. Hepatol. 2003; 38: 257-65.
29. Wong VW, Chan HL, Hui AY etal. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese. Aliment. Pharmacol. Ther. 2004; 20: 45-9.
30. Nugent C, Younossi ZM. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007; 4: 432-41.
31. Adams LA, Lymp JF, St Sauver J etal. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
32. Marcellin P, Ziol M, Bedossa P etal. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29: 242-7.
33. Oliveri F, Coco B, Ciccorossi P etal. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J. Gastroenterol. 2008; 14: 6154-62.
34. Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, Nakajima A. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1.
35. Fung J, Lai CL, Chan SC etal. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am. J. Gastroenterol. 2010; 105: 1116-22.
36. Hourigan LF, Macdonald GA, Purdie D etal. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-9.
37. Kim SU, Kim do Y, Ahn SH etal. The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B. Hepatogastroenterology 2010; 57: 832-8.
38. Lupsor M, Stefanescu H, Sparchez Z. The influence of fatty load on liver stiffness in chronic hepatitis C patients. J. Hepatol. 2008; 48 (Suppl. 2): S278.